Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IPIX, the "poor" man's rocket ride. Who needs SpaceX and Blue Origin.
What is going on? The time has come for an investigation, it seems to me. The stock holders need to find out what, why, and who is behind the fall of a company’s stock from nearly $5 to nearly $0.05. While that is not uncommon, it is very strange for a company with such a promising drug as Brilacidin - a drug that has been deemed worthy of FDA Fast Tracking, a drug with multiple actions, a drug which has successfully completed Phase 2 trial for OM, a drug that has shown promise for treating the scourge of Covid-19, and more. I don’t know anything about the rights of shareholders to institute such an investigation. Perhaps all that has gone on is legal, perhaps not. Perhaps all that has gone on is best for carrying out drug development in the US, perhaps not. Perhaps all that has gone on is best for business competition and stock price setting, perhaps not. Perhaps all that has gone on would get the approval of an ethicist even as people are dying and suffering, perhaps not. So it is not just a search for illegality, but a hope to have a window on flaws in the system that need correction for the good of mankind. IPIX might be regarded as just a case study. If you know what can be done, let’s hear from you. If it requires some money, do you think we can raise it by crowdfunding? Do you agree that it is time already for us to know all that has gone on? Surely we can best justify time spent on this board if it helps us develop some deeper, real-world knowledge about stocks and investing? Ideas?
What is everybody's opinion about whether anything illegal or conspiratorial has been done to driven the SP of IPIX down to such a low (I would say absurd) level? For the good of future drug development, the protection of small companies, and my own curiosity (probably many people's), the case of IPIX and B should be examined. Incidentally, I have written over the past few year (pre-Covid) to three media giants saying not only is B a potentially valuable drug in the medical arsenal, but the whole history of B and of IPIX/CTIX would make for a fascinating story (expose?). I never got a reply. At the drop of a hat the lawyers will start investigating and preparing to sue the actions of CEO's (even Mickey Mouse now). It is essential to know whether, in these catastrophic times, there is any conspiracy out there that, even now. is trying to hold back IPIX and B. What if it turns out that B really helps in the fight against Covid, and what if IPIX had had the financing and SP to afford to get B approved years ago (for any use)? Would I still be sheltering at home? How many more people would still be alive? It is no longer just a case of the money some of us have lost (of course, only so far). If everything was done within the rules, then I accept that, but it is the rules that need examination.
The attention contributors are turning towards why the stock price is so low and B is not receiving the attention it deserves is exactly what I think has been needed for a long time. I don't know what stock owners' legal rights are with respect to investigation, but others here might. I, myself, have contacted a couple major media outlets. Honestly, I think the IPIX history would make a great story filled with intrigue, interesting characters, surprising twists and turns, government dallying, lack of support for drug development, etc. For instance, why are there people who contribute to the IPIX board (even thousands of times) and contribute to no other or only have a few other contributions to other boards. Are they working on someone else's behalf? I have noted all that in my correspondence, and that it could even become an expose. No response. It's a pity because they have the investigative resources needed. Does anyone have an in to a member of the media noted for investigative journalism? Or maybe a financial crimes investigator is needed. Let's keep at getting to the full story. I look forward to seeing more comments on the subject of what is going on and what stock owners can do about it.
Here is a speculation, possibility, or call it what you may: Some Big Pharma (BPX) is willing to buy a 50% interest in IPIX. How does IPIX arrange that. One way is to ask for stock holders to sell shares to BPX at some set price. This can get cumbersome since some large holders frequently hold out for a higher price. I've been through that, and so have many of you, I'm sure. Another way is as follows. Let's say, arbitrarily, this company has 300M shares outstanding. They get the shareholders to approve authorization to issue 300M more shares, which holders probably will since they suspect the company must have cash from the sale to continue their work, survive and prosper. They then sell the 300M shares. at some prearranged price, to BPX.
Excuse me if someone has already suggested something along these lines, but it is hard to keep up with every post.
As long as we are just speculating, let's speculate that the price is $20 a share.
I can tell what is motivating Menon probably and he is undoubtedly working very hard to develop ultra successful drugs. As a scientist myself, I would say that he is feeling the pull of a possible Nobel Prize for breakthrough drugs, such as an antibiotic that resists microbe mutations. There are many multimillionaires but far fewer Nobel Prize winners. We IPIX longs are pulling for him. The rest of the world should be, too. It is hard to understand that there are people out there who are so interested in the buck that they would put up obstacles to, indeed sabotage, breakthrough drug development. If they are not trying to ruin IPIX, why are they so interested in giving us investors "advise," and wasting their time writing hundreds of doomsday forum entries on this board?
Why shouldn’t Sigma Labs experience the spike it did Friday? They have a fabulous product which the 3D printing industry will absolutely need once AM really gets going. That is why I bought SGLB in 2013, unfortunately at $16.63 and am still holding it. Plenty others thought it worthwhile buying in 2013 at those prices. I also was impressed with the background of the people involved.
Allow me to compare SGLB with Camtek, described in their SEC filing: “We design, develop, manufacture and market products mainly based on our core technology- [Automated Optical Inspection]. AOI systems optically inspect various types of electronic product components for defects caused during the manufacturing process.” Camtek was up 52% in 2016, is ahead 88% YTD, and has been ahead even more at times this year. Why not SGLB? Quality control is a big deal in the manufacturing process, especially for critical components. I am not minimizing the fact that Camtek is making money, and that semiconductors are a hot industry. This will come for SGLB. Good luck to them, for the sake of my recovery, and because they can provide an essential component for the advancement of all of Additive Manufacturing.
I hope it is done in the US. Isn’t that what America is trying so hard to achieve? Too bad SGLB has recently had to go abroad to move forward. Earlier the US put so much effort into 3D printing through America Makes, the DoD support, the Additive Manufacturing Consortium, and the early interests of GE, Honeywell, and others (as well as the investment community). Are we serious about creating good American industries and job? Then let’s see some support for the needed research, development, investment, and risk taking. Instead what we see are American firms, focus on products that will create jobs or heal the sick, but are being impeded by “short and distort” schemes. (I hope none of the recent posters are in this class.) Is this really the best way some people can find to amass wealth? How about working for the common good?
I would love to see a discussion on Ihub of the pros and cons of the various options for raising cash. In particular I have in mind going to Aspire vs. releasing additional stock under the terms of the shelf registration. Maybe throw in consideration of partnership and the relative merits of an immediate partnership vs. raising cash to further delay partnership. How much is and will Aspire selling contributing to the SP suppression? Will a new stock release go to long term investors (I would buy in to preserve my fractional share of the company). Personally, I have added a bit lately (I have already well exceeded prudence) and it bothers me that I may be buying from someone who is selling short or in other ways damaging the company. It seems to me that taking some action to raise cash would relieve some of the fears about the company's future, and this might more than compensate in SP for the effect of dilution.
Is there anything that the SEC can do about DeVries/Mako and Rosen?
I have sent a message to 60 minutes suggesting that they investigate and report on the unscrupulous manipulation of stock prices by shorters. In part:
May I suggest a subject that would make an excellent and important 60 Minutes segment: The manipulation of stock prices by market makers, traders, and other rogues. There is an excellent example of this involving a company called Cellceutix (CTIX). The story is very long and you will have to investigate it yourself, but it is all laid out on the internet. See CTIX's site, and InvestorsHub in particular to begin with. Another start might be the letter to shareholders from the CEO:
http://us2.campaign-archive1.com/?u=9ed1a6b082ae8962468007971&id=ab67dc40ca&e=4a9c0df4f3
in which many of the issues are summarized, although in a different context...
Although the pump-and-dump schemes are familiar from several movies, the short-and-distort schemes are less well known. The CTIX affair is a dramatic and compelling example, with practically every aspect of the practice: psychological sales, false publications anonymously (can you possibly unmask the Mako villain), baseless law suits, etc., all meant to drive down the price of a stock for the benefit of short sellers.
I do not get to see every message so maybe this has been done already, but more letters will not hurt. Go [url tag="here" ] http://www.cbs.com/feedback/ [/url]
Look forward to meeting many of you at the Annual Meeting.
Today Nevro submitted and posted a link to their preliminary response to the patent trial and appeals board with reference to the Boston Scientific Corporation challenge to the key Nevro patent.
See http://www.nevro.com/press-release/?r=US&prid=5aa76c3f-164d-4b00-8def-f9ad36ba33b2. I personally, though not a lawyer, was impressed by the strength of the rebuttal.
On another note, I have heard that the first few patients in my state that have received the preliminary trial for effectiveness of the Senza have faired well, and are going to move on to permanent implants. A number of advisory services have not been favorably viewing Nevro, but IMO that is because they are looking at past performance and not considering the game change that FDA approval represents. Others that look at the whole picture, such as Zacks, are very high on NVRO (Rank 1).
Long on NVRO, and added on the recent dip. The sparseness of contributions to this board is an indication that the stock is flying under the radar. I was clued in when the Senza was recommended for my spouse.
To the shorts: You never can tell what will happen to make CTIX take a quantum leap. I have something in mind. When and if it happens I will tell you my little role in it. Unlike the SA article, I am in CTIX for the long run so I don't really care financially about this playing around; and this is not a pump and dump. I understand that this is your business and you probably make a lot doing it, but with the upside potential of CTIX I would advise caution. Right now my biggest concern is getting these lifesaving drugs out to the world. I have a cousin who died from MRSA.
I think several factors are contributing to the drop today. One is that there is disappointment in the length of time it will take for the approval of the drugs in testing phases. In this regard, does anyone on the board know how the approval time for small, developmental biotech firms compares with big pharma. If significant, can we get after the FDA or our Congressmen or someone? Another factor is the lack of much new in the presentation yesterday. Leo, I think, may have released the results early last week in order to cut off the raiders trying to attack CTIX, but that left little sensational for the conference. So PS went up then on the news and down now on disappointment about mostly "old" news. Of course, the traders (viz. investors) jump on every potential dip and cause it to exaggerate. As many have said: so what, if your not selling; and thank you if your in a position and are inclined to buy more. With the doubling this year I'm already over 20% of portfolio in CTIX since I haven't sold a thing. I'd love to buy more, but have to exercise some prudence. I wonder where everyone else is %-wise. I realize this depends on many factors, though.
Another way of looking at the B data that Leo released this morning for the various arms of the study, and I think a better way, is that the probabilities of not being cured by the various regimens are: 7.8% for 0.6 mg/kg single dose B; 4.2% for 0.8 mg/kg single dose B; 1.9% for 1.2 mg/kg 3 day dose B(does that mean 0.6 per dose?); 6.2% for daptomycin 7 day. I am a mathematical scientist who frequently has used statistics, and I would always record data as failure rates when the success rate was so high, to make the results clearer. For instance, in the present case would you tell a patient that B regimen 3 is only 4.3% more effective than D's regimen, or would you say that your chance that you are not going to be cured is more than 3 times as great with the D regimen as with the B regimen 3.
Do the golden parachutes seem excessive? Should they have been smaller and the payment to shareholders correspondingly higher? How should the proxy be voted on the golden parachute issue? So far I intend to vote yes on the merger.
Submitted an email to President Obama via www.whitehouse.gov. Said that the key to the antibiotic resistance problem may already be there and urged him to see if the testing, analysis, and approval processes can be speeded up. I suggested that he have someone contact CTIX to see what Leo thinks that the government might be able to do to speed things up and help out.
This is my first post to the board but I have been following it for a long time. Came across CTIX via Seeking Alpha and made my first purchase in 2013 at $2.24. Bought some more as SP fell but then I got discouraged as they continued to fall. In 2014 I found this board, though. I want to thank all the contributors for the many facts and analyses that were expose here, which finally lead me to resume accumulating; and, oh, yes, I find the enthusiasm and optimism delightful, too. Can I get invited to the party now?